You just read:

Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

News provided by

Dragonfly Therapeutics, Inc.

Mar 19, 2020, 09:00 ET